CPIG
TSHA icon

Chicago Partners Investment Group’s Taysha Gene Therapies TSHA Stock Holding History

Chicago Partners Investment Group’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.15M Buy
170,751
+4,210
+3% +$19.6K 0.03% 490
2025
Q4 		$776K Buy
166,541
+2,504
+2% +$12.2K 0.02% 550
2025
Q3 		$819K Buy
164,037
+271
+0.2% +$767 0.02% 487
2025
Q2 		$441K Buy
163,766
+47,201
+40% +$103K 0.01% 652
2025
Q1 		$221K Buy
116,565
+521
+0.4% +$871 0.01% 825
2024
Q4 		$224K Sell
116,044
-2,131
-2% -$4.42K 0.01% 776
2024
Q3 		$233K Buy
118,175
+1,270
+1% +$2.79K 0.01% 706
2024
Q2 		$263K Sell
116,905
-8,379
-7% -$24.4K 0.01% 630
2024
Q1 		$317K Sell
125,284
-9,567
-7% -$19.9K 0.01% 558
2023
Q4 		$198K Buy
134,851
+23,740
+21% +$47.3K 0.01% 663
2023
Q3 		$242K Buy
+111,111
New +$208K 0.01% 559

Other funds holding TSHA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Chicago Partners Investment Group's TSHA Position: Q1 2026 in Review

Chicago Partners Investment Group increased its Taysha Gene Therapies (TSHA) stake by 2.5% in Q1 2026, buying an estimated $19.6K and bringing the position to 170,751 shares worth $1.15M. The position accounts for 0.03% of the portfolio, ranked #490.

Chicago Partners Investment Group first reported a position in TSHA in Q3 2023 and has held it in 11 quarters since. 191 funds tracked by Wall St. Rank hold TSHA as of Q1 2026.

  • Chicago Partners Investment Group held 170,751 shares of Taysha Gene Therapies worth $1.15M as of Q1 2026.
  • Chicago Partners Investment Group bought 4,210 Taysha Gene Therapies shares in Q1 2026, an estimated $19.6K.
  • Taysha Gene Therapies made up 0.03% of Chicago Partners Investment Group's portfolio in Q1 2026, its #490 holding.
  • Chicago Partners Investment Group first reported a position in Taysha Gene Therapies in Q3 2023 and has held it in 11 quarters since.
  • 191 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q1 2026.

Based on Chicago Partners Investment Group's 13F filing for Q1 2026, filed 4 May 2026.